|
1
|
Freeman JM: Febrile seizures: A consensus
of their significance, evaluation, and treatment. Pediatrics.
66:10091980.PubMed/NCBI
|
|
2
|
Karaagac N, Yeni SN, Senocak M, Bozluolcay
M, Savrun FK, Ozdemir H and Cagatay P: Prevalence of epilepsy in
Silivri, a rural area of Turkey. Epilepsia. 40:637–642. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Molina-Carballo A, Muñoz-Hoyos A,
Sanchez-Forte M, Uberos-Fernandez J, Moreno-Madrid F and
Acuna-Castroviejo D: Melatonin increases following convulsive
seizures may be related to its anticonvulsant properties at
physiological concentrations. Neuropediatrics. 38:122–125. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Molina-Carballo A, Acuna-Castroviejo D,
Rodriguez-Cabezas T and Muñoz-Hoyos A: Effects of febrile and
epileptic convulsions on daily variations in plasma melatonin
concentration in children. J Pineal Res. 16:1–9. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
ENCODE Project Consortium: An integrated
encyclopedia of DNA elements in the human genome. Nature.
489:57–74. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gibb EA, Brown CJ and Lam WL: The
functional role of long non-coding RNA in human carcinomas. Mol
Cancer. 10:382011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brunner AL, Beck AH, Edris B, Sweeney RT,
Zhu SX, Li R, Montgomery K, Varma S, Gilks T, Guo X, et al:
Transcriptional profiling of long non-coding RNAs and novel
transcribed regions across a diverse panel of archived human
cancers. Genome Biol. 13:R752012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ponting CP, Oliver PL and Reik W:
Evolution and functions of long noncoding RNAs. Cell. 136:629–641.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang Y, Liu X, Bai X, Lin Y, Li Z, Fu J,
Li M, Zhao T, Yang H, Xu R, et al: Melatonin prevents endothelial
cell pyroptosis via regulation of long noncoding RNA
MEG3/miR-223/NLRP3 axis. J Pineal Res. 64:37–38. 2018. View Article : Google Scholar
|
|
11
|
Zhu X, Shen H, Yin X, Yang M, Wei H, Chen
Q, Feng F, Liu Y, Xu W and Li Y: Macrophages derived exosomes
deliver miR-223 to epithelial ovarian cancer cells to elicit a
chemoresistant phenotype. J Exp Clin Cancer Res. 38:812019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li DM and Sun H: TEP1, encoded by a
candidate tumor suppressor locus, is a novel protein tyrosine
phosphatase regulated by transforming growth factor beta. Cancer
Res. 57:2124–2129. 1997.PubMed/NCBI
|
|
13
|
Myers MP, Pass I, Batty IH, Van der Kaay
J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP and Tonks NK: The
lipid phosphatase activity of PTEN is critical for its tumor
supressor function. Proc Natl Acad Sci USA. 95:13513–13518. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Maehama T and Dixon JE: The tumor
suppressor, PTEN/MMAC1, dephosphorylates the lipid second
messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem.
273:13375–13378. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stambolic V, Suzuki A, de la Pompa JL,
Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM,
Siderovski DP and Mak TW: Negative regulation of PKB/Akt-dependent
cell survival by the tumor suppressor PTEN. Cell. 95:29–39. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hopkins BD, Hodakoski C, Barrows D, Mense
SM and Parsons RE: PTEN function: The long and the short of it.
Trends Biochem Sci. 39:183–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhu F, Kai J, Chen L, Wu M, Dong J, Wang Q
and Zeng LH: Akt inhibitor perifosine prevents epileptogenesis in a
rat model of temporal lobe epilepsy. Neurosci Bull. 34:283–290.
2018. View Article : Google Scholar :
|
|
18
|
Zhao Y, Han Y, Bu DF, Zhang J, Li QR, Jin
HF, Du JB and Qin J: Reduced AKT phosphorylation contributes to
endoplasmic reticulum stress-mediated hippocampal neuronal
apoptosis in rat recurrent febrile seizure. Life Sci. 153:153–162.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Freyd T, Warszycki D, Mordalski S,
Bojarski AJ, Sylte I and Gabrielsen M: Ligand-guided homology
modelling of the GABAB2 subunit of the GABAB receptor. PLoS One.
12:e01738892017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhang B, McDaniel SS, Rensing NR and Wong
M: Vigabatrin inhibits seizures and mTOR pathway activation in a
mouse model of tuberous sclerosis complex. PLoS One. 8:e574452013.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
MacKenzie G and Maguire J: Chronic stress
shifts the GABA reversal potential in the hippocampus and increases
seizure susceptibility. Epilepsy Res. 109:13–27. 2015. View Article : Google Scholar
|
|
22
|
Xu XK, Wang SY, Chen Y, Zhan L, Shao ZY,
Lin L, Yan WC and Mei SF: Fangjing decoction relieves febrile
seizures-induced hippocampal neuron apoptosis in rats via
regulating the Akt/mTOR pathway. Biosci Rep. 38:BSR201812062018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
National Research Council (US) Committee
for the Update of the Guide for the Care and Use of Laboratory
Animals: Guide for the Care and Use of Laboratory Animals. 8th
edition. National Academies Press (US); Washington, DC: 2011
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
25
|
Stehle JH, Saade A, Rawashdeh O, Ackermann
K, Jilg A, Sebesteny T and Maronde E: A survey of molecular details
in the human pineal gland in the light of phylogeny, structure,
function and chronobiological diseases. J Pineal Res. 51:17–43.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Acuña-Castroviejo D, Escames G, Venegas C,
Díaz-Casado ME, Lima-Cabello E, López LC, Rosales-Corral S, Tan DX
and Reiter RJ: Extrapineal melatonin: Sources, regulation, and
potential functions. Cell Mol Life Sci. 71:2997–3025. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Manchester LC, Coto-Montes A, Boga JA,
Andersen LP, Zhou Z, Galano A, Vriend J, Tan DX and Reiter RJ:
Melatonin: An ancient molecule that makes oxygen metabolically
tolerable. J Pineal Res. 59:403–419. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Reiter RJ, Mayo JC, Tan DX, Sainz RM,
AlatorreJimenez M and Qin L: Melatonin as an antioxidant: Under
promises but over delivers. J Pineal Res. 61:253–278. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lax P, Otalora BB, Esquiva G, Rol Mde L,
Madrid JA and Cuenca N: Circadian dysfunction in P23H rhodopsin
transgenic rats: Effects of exogenous melatonin. J Pineal Res.
50:183–191. 2011.
|
|
30
|
Yu L, Liang H, Dong X, Zhao G, Jin Z, Zhai
M, Yang Y, Chen W, Liu J, Yi W, et al: Reduced silent information
regulator 1 signaling exacerbates myocardial ischemia-reperfusion
injury in type 2 diabetic rats and the protective effect of
melatonin. J Pineal Res. 59:376–390. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yu L, Liang H, Lu Z, Zhao G, Zhai M, Yang
Y, Yang J, Yi D, Chen W, Wang X, et al: Membrane receptor-dependent
Notch1/Hes1 activation by melatonin protects against myocardial
ischemia-reperfusion injury: In vivo and in vitro studies. J Pineal
Res. 59:420–433. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Favero G, Rodella LF, Reiter RJ and
Rezzani R: Melatonin and its atheroprotective effects: A review.
Mol Cell Endocrinol. 382:926–937. 2014. View Article : Google Scholar
|
|
33
|
Chen Q, Qin R, Fang Y and Li H: Berberine
sensitizes human ovarian cancer cells to cisplatin through
miR-93/PTEN/Akt signaling pathway. Cell Physiol Biochem.
36:956–965. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Keniry M and Parsons R: The role of PTEN
signaling perturbations in cancer and in targeted therapy.
Oncogene. 27:5477–5485. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Cowell JK, Qin H, Hu T, Wu Q, Bhole A and
Ren M: Mutation in the FGFR1 tyrosine kinase domain or inactivation
of PTEN is associated with acquired resistance to FGFR inhibitors
in FGFR1-driven leukemia/lymphomas. Int J Cancer. 141:1822–1829.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lue H, Thiele M, Franz J, Dahl E,
Speckgens S, Leng L, Fingerle-Rowson G, Bucala R, Luscher B and
Bernhagen J: Macrophage migration inhibitory factor (MIF) promotes
cell survival by activation of the Akt pathway and role for
CSN5/JAB1 in the control of autocrine MIF activity. Oncogene.
26:5046–5059. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Han Z, Chen F, Ge X, Tan J, Lei P and
Zhang J: miR-21 alleviated apoptosis of cortical neurons through
promoting PTEN-Akt signaling pathway in vitro after experimental
traumatic brain injury. Brain Res. 1582:12–20. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Reynolds C, Roderick JE, LaBelle JL, Bird
G, Mathieu R, Bodaar K, Colon D, Pyati U, Stevenson KE, Qi J, et
al: Repression of BIM mediates survival signaling by MYC and AKT in
high-risk T-cell acute lymphoblastic leukemia. Leukemia.
28:1819–1827. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sonoda Y, Mukai H, Matsuo K, Takahashi M,
Ono Y, Maeda K, Akiyama H and Kawamata T: Accumulation of
tumor-suppressor PTEN in Alzheimer neurofibrillary tangles.
Neurosci Lett. 471:20–24. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kwak YD, Ma T, Diao S, Zhang X, Chen Y,
Hsu J, Lipton SA, Masliah E, Xu H and Liao FF: NO signaling and
S-nitrosylation regulate PTEN inhibition in neurodegeneration. Mol
Neurodegener. 5:492010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Napoli E, Ross-Inta C, Wong S, Hung C,
Fujisawa Y, Sakaguchi D, Angelastro J, Omanska-Klusek A, Schoenfeld
R and Giulivi C: Mitochondrial dysfunction in Pten
haplo-insufficient mice with social deficits and repetitive
behavior: Interplay between Pten and p53. PLoS One. 7:e425042012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Liang H, He S, Yang J, Jia X, Wang P, Chen
X, Zhang Z, Zou X, McNutt MA, Shen WH and Yin Y: PTENα, a PTEN
isoform translated through alternative initiation, regulates
mitochondrial function and energy metabolism. Cell Metab.
19:836–848. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Zheng X, Zu L, Becker L and Cai ZP:
Ischemic preconditioning inhibits mitochondrial permeability
transition pore opening through the PTEN/PDE4 signaling pathway.
Cardiology. 129:163–173. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hu N, Dong M and Ren J: Hydrogen sulfide
alleviates cardiac contractile dysfunction in an Akt2-knockout
murine model of insulin resistance: Role of mitochondrial injury
and apoptosis. Am J Physiol Regul Integr Comp Physiol.
306:R761–R771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kwon CH, Luikart BW, Powell CM, Zhou J,
Matheny SA, Zhang W, Li Y, Baker SJ and Parada LF: Pten regulates
neuronal arborization and social interaction in mice. Neuron.
50:377–388. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Lugo JN, Smith GD, Morrison JB and White
J: Deletion of PTEN produces deficits in conditioned fear and
increases fragile X mental retardation protein. Learn Mem.
20:670–673. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Backman SA, Stambolic V, Suzuki A, Haight
J, Elia A, Pretorius J, Tsao MS, Shannon P, Bolon B, Ivy GO and Mak
TW: Deletion of Pten in mouse brain causes seizures, ataxia and
defects in soma size resembling Lhermitte-Duclos disease. Nat
Genet. 29:396–403. 2001. View
Article : Google Scholar : PubMed/NCBI
|
|
48
|
Clipperton-Allen AE and Page DT: Decreased
aggression and increased repetitive behavior in Pten
haploinsufficient mice. Genes Brain Behav. 14:145–157. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Smith GD, White J and Lugo JN:
Superimposing status epilepticus on neuron subset-specific PTEN
haploinsufficient and wild type mice results in long-term changes
in behavior. Sci Rep. 6:365592016. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Sun H, Lesche R, Li DM, Liliental J, Zhang
H, Gao J, Gavrilova N, Mueller B, Liu X and Wu H: PTEN modulates
cell cycle progression and cell survival by regulating
phosphatidylinositol 3,4,5,-trisphosphate and Akt/protein kinase B
signaling pathway. Proc Natl Acad Sci USA. 96:6199–6204. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Liu JL, Sheng X, Hortobagyi ZK, Mao Z,
Gallick GE and Yung WK: Nuclear PTEN-mediated growth suppression is
independent of Akt down-regulation. Mol Cell Biol. 25:6211–6224.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Blanco-Aparicio C, Renner O, Leal JF and
Carnero A: PTEN, more than the AKT pathway. Carcinogenesis.
28:1379–1386. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Arencibia JM, Pastor-Flores D, Bauer AF,
Schulze JO and Biondi RM: AGC protein kinases: From structural
mechanism of regulation to allosteric drug development for the
treatment of human diseases. Biochim Biophys Acta. 1834:1302–1321.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Liao Y and Hung MC: Physiological
regulation of Akt activity and stability. Am J Transl Res. 2:19–42.
2010.PubMed/NCBI
|
|
56
|
Scheid MP and Woodgett JR: Unravelling the
activation mechanisms of protein kinase B/Akt. FEBS Lett.
546:108–112. 2003. View Article : Google Scholar : PubMed/NCBI
|
